| Hop | Node | Community | Role |
|---|---|---|---|
| 0 | Adrenochrome | 11 | Oxidation product of adrenaline/epinephrine |
| 1 | Carbazrome | 71 | Further oxidation product; engages Complex I/III |
| 2 | Mitohormetic Redox-Relay | 36 | Signaling hub linking mitochondrial ROS to adaptive responses |
| 3 | SIRT1 | 17/36 | NAD⁺-dependent deacetylase — master metabolic regulator |
Community boundaries crossed: 11 → 71 → 36 → 17
Adrenochrome is reduced by Complex I of the mitochondrial electron transport chain (ETC) via a one-electron transfer, generating an o-semiquinone radical intermediate. This semiquinone reacts rapidly with molecular oxygen (k ≈ 9 × 10⁸ M⁻¹s⁻¹), producing superoxide anion (O₂⁻) and regenerating adrenochrome — establishing a self-sustaining redox cycle.
<aside> ℹ️ Source: Bindoli et al., 1990 (BBA Bioenergetics, 1016:349-356) "The toxic effects of adrenochrome and its pathophysiological role can be explained, at least in part, on the basis of the demonstrated cycle."
</aside>
<aside> ℹ️ Source: Genova et al., 2006 (Arch Biochem Biophys, 448:22-29) Complex I catalyses the NADH-supported generation of superoxide; adrenaline is oxidised by superoxide to adrenochrome, which is reduced by Complex I, establishing a redox cycle that amplifies superoxide production.
</aside>
Key players in the cycle:
The superoxide generated by adrenochrome redox cycling triggers mitohormesis — a biphasic response where low-dose mitochondrial ROS acts as a signaling molecule rather than a damage agent.
<aside> 💡 Key Concept: Mitohormesis Low, non-cytotoxic concentrations of ROS promote mitochondrial homeostasis through activation of antioxidant defense, mitophagy, and biogenesis pathways. This is distinct from high-dose oxidative stress which causes damage.
</aside>
Mitohormetic signaling cascade: